IN INBRAIN NEUROELECTRONICS
LIVE

Serial Number

98738185

Owner

INBRAIN Neuroelectronics SL

Attorney

B. Anna McCoy

Filing Date

Sep 6, 2024

Add to watchlist:

No watchlists yet
View on USPTO

IN INBRAIN NEUROELECTRONICS Trademark

Serial Number: 98738185 • Registration: 8191439

IN INBRAIN NEUROELECTRONICS is a trademark filed by INBRAIN Neuroelectronics SL on September 6, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

INBRAIN Neuroelectronics SL (6 trademarks)

Reixac, 4-8 Edificio ClĂșster II Planta 3
Oficinas D8, Barcelona 08028 , ES

Entity Type: 99

Trademark Details

Filing Date

September 6, 2024

Registration Date

March 31, 2026

Published for Opposition

February 10, 2026

Goods & Services

Implantable and non-implantable medical devices for stimulation and monitoring of brain activity; Diagnostic, examination, and monitoring equipment, namely, neurostimulation and neuromodulation device and upgradeable recorded integrated software for monitoring components; Medical and veterinary apparatus and instruments for neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Diagnostic, examination, and monitoring equipment for use in treatment of patients in the neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation field of neural implants, namely, neuromodulation and brain computer interface system components, namely, electrodiagnostic automated constant current sinusoid waveform neuroselective sensory nerve testing devices in the nature of electrodes, and upgradeable recorded integrated software for the control and application of neuromodulation and its applied therapeutic response; Electric nerve stimulators; Electronic nerve stimulators; Nerve muscle stimulators; transcutaneous electrical muscle stimulators; Electronic stimulators for neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Medical leads for use with implantable nerve stimulators; Medical monitoring instruments, namely, neural interfaces, brain computer interfaces and other implantable sensors

Providing medical services in the nature of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation services; Physical therapy services; Development of individual physical rehabilitation programs; Providing physical rehabilitation services, namely, provision of exercise facilities specifically for health rehabilitation services; Consulting services in the medical fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation services

Neural computer interfaces for neuromodulation therapies that allow users to interface with computer hardware via brain activity; Downloadable artificial intelligence software for improving medical therapies, namely, for therapy personalization; Monitoring equipment and instruments, namely, computer display monitors

Computer technical support services, namely, 24/7 IT support desk services for support in the use of medical apparatus and instruments; Science and technology services in the nature of medical research and development of treatments in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Testing, authentication and quality control for others of medical apparatus and instruments; Design services for medical apparatus and instruments; medical research services; Natural science services in the nature of medical research; clinical research in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; biomedical research services; Scientific research in the nature of conducting clinical trials in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Scientific investigations for medical purposes; Engineering research in the field of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation; Software engineering; Mechanical engineering, especially medical engineering in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, and physical rehabilitation

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 13, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2025 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 16, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 10, 2025 PBCR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 16, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 16, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 16, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 2, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 2, 2025 GNFR
FINAL REFUSAL WRITTEN
Sep 2, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 19, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 17, 2025 NWOS
NEW APPLICATION ENTERED
Sep 6, 2024 NWAP